NEW YORK (GenomeWeb) – Canon BioMedical said today that it has signed a distribution deal in Benelux for its Novalelle genotyping assays.
Under the agreement, Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon BioMedical's entire portfolio of Novallele assays, controls, and reagents in the region.
The research-use-only Novallele genotyping assays detect genetic variations using PCR followed by high-resolution melting analysis and can be performed on any thermal cycler capable of HRM. The Novallele control sets, including wild-type, heterozygous mutant, and homozygous mutant variants are useful for experiments without an available reference sample, the company noted.